Literature DB >> 12078834

Long-term health consequences of PCOS.

Robert A Wild1.   

Abstract

The prevalence of cardiovascular risk factors, insulin resistance/diabetes and/or uterine pathology appears to be increased in women with polycystic ovarian syndrome (PCOS), although more outcome studies are necessary to determine incidence. Data pertaining to some of the potential long-term health consequences associated with PCOS are summarized. Medline, Current Contents and PubMed were searched for studies from the time of our original interest in this issue in 1980 to the present. The review is limited to published human data. The current literature indicate that women with this syndrome cluster risk factors for premature morbidity and mortality. Large multi-site co-operative studies are necessary to evaluate the long-term health outcomes.

Entities:  

Mesh:

Year:  2002        PMID: 12078834     DOI: 10.1093/humupd/8.3.231

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  34 in total

1.  Long term health consequences of polycystic ovarian syndrome: a review analysis.

Authors:  A Daniilidis; K Dinas
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

Review 2.  Diagnostic criteria for polycystic ovarian syndrome.

Authors:  F J Broekmans; B C J M Fauser
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 3.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

4.  Risk of cardiovascular events in patients with polycystic ovary syndrome.

Authors:  S Iftikhar; M L Collazo-Clavell; V L Roger; J St Sauver; R D Brown; S Cha; D J Rhodes
Journal:  Neth J Med       Date:  2012-03       Impact factor: 1.422

Review 5.  Comparison of dietary intake and physical activity between women with and without polycystic ovary syndrome: a review.

Authors:  Annie W Lin; Marla E Lujan
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

6.  Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.

Authors:  Jalini Joharatnam; Thomas M Barber; Lisa Webber; Gerard S Conway; Mark I McCarthy; Stephen Franks
Journal:  Clin Endocrinol (Oxf)       Date:  2011-06       Impact factor: 3.478

7.  Reproductive history and hormonal birth control use are associated with coronary calcium progression in women with type 1 diabetes mellitus.

Authors:  Janet K Snell-Bergeon; Dana Dabelea; Lorraine G Ogden; John E Hokanson; Gregory L Kinney; James Ehrlich; Marian Rewers
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

8.  Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.

Authors:  D Romualdi; S De Cicco; M Busacca; D Gagliano; A Lanzone; M Guido
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

Review 9.  11-Oxygenated androgens in health and disease.

Authors:  Adina F Turcu; Juilee Rege; Richard J Auchus; William E Rainey
Journal:  Nat Rev Endocrinol       Date:  2020-03-16       Impact factor: 43.330

Review 10.  Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?

Authors:  Suvarna Satish Khadilkar
Journal:  J Obstet Gynaecol India       Date:  2016-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.